Pfizer Inc. (PFE) informed Icagen Inc.'s (ICGN) board in a letter Friday that its best and final offer price for the biopharmaceutical company was $6 a share, Reuters reported.

Pfizer said it wouldn't raise its offer even if a majority of the Icagen shares aren't tendered, according to Reuters.

Full story at http://www.reuters.com/article/2011/08/26/us-pfizer-idUSTRE77P54R20110826?feedType=RSS&feedName=innovationNews&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FdealsNews+%28News+%2F+US+%2F+Deals+News%29

-Dow Jones Newswires; 212-416-2900

Icagen, Inc. (MM) (NASDAQ:ICGN)
Graphique Historique de l'Action
De Fév 2025 à Mar 2025 Plus de graphiques de la Bourse Icagen, Inc. (MM)
Icagen, Inc. (MM) (NASDAQ:ICGN)
Graphique Historique de l'Action
De Mar 2024 à Mar 2025 Plus de graphiques de la Bourse Icagen, Inc. (MM)